Oncology Times

Skip Navigation LinksHome > Blogs > FRESH SCIENCE for Clinicians > A Little More on the Intellectual Property Issue...
FRESH SCIENCE for Clinicians
News about basic science of interest and relevance for cancer clinicians
Monday, February 28, 2011
A Little More on the Intellectual Property Issue...


After writing my last post about the bedside micro-NMR (µNMR) device that might speed cancer diagnosis, I remained curious about the lack of financial conflicts.


One of the lead authors on the paper, Cesar M. Castro, MD, an oncologist at Massachusetts General Hospital, was kind enough to provide more details. He said MGH holds the patent on the device and that the technology is not currently licensed to an outside group.


“As far as I know, there are no plans to pursue commercialization or strategic partnerships in the near future as we seek to further optimize the device,” Dr. Castro wrote in an email message. “Moreover, we have enough non-dilutive funding secured through scientific grants to allow us to continue the course.”


I’m glad to have the extra information, and I’ll be looking forward to seeing their next paper.

About the Author

Rabiya S. Tuma, PhD
RABIYA S. TUMA, PHD, a Contributing Writer for Oncology Times, is an award winning journalist and a regular contributor to The Economist, and the Journal of the National Cancer Institute. Her work has appeared in a variety of publications including CR Magazine, Yoga + Joyful Living, O The Oprah Magazine, HHMI Bulletin, and the New York Times. Prior to launching her writing career, Rabiya earned her doctorate at the University of Washington and Fred Hutchinson Cancer Research Center and worked at a biotechnology firm in Eugene, Oregon. And though she traded a lab bench for a computer, she remains fascinated with the work that takes basic science into the clinic.

Her OT blog was recognized this year by the American Society of Healthcare Publication Editors (ASHPE) with a bronze award in the category of Best Blog.